- portada
- temas comerciales
- adpic
- taller 27 de octubre de 2015
27 de octubre de 2015
PROPIEDAD INTELECTUAL: TALLER CONJUNTO DE LA OMS, LA OMPI Y LA OMC
Taller sobre los criterios de patentabilidad
El 27 de octubre de 2015 se celebró un taller técnico sobre los criterios de patentabilidad, organizado conjuntamente por la Organización Mundial de la Salud, la Organización Mundial de la Propiedad Intelectual y la OMC. En el taller los participantes adquirieron nociones concretas sobre el modo en que se aplican los principales criterios sustantivos de patentabilidad en la práctica en los distintos países, y acerca de la forma en que las diversas definiciones e interpretaciones pueden repercutir en la salud pública.
English only
The aim was to support participants to engage in a policy debate that is characterized by its highly technical nature and assist them to appropriately frame and assess national patent systems and practices. To do so, the three collaborating agencies provided a brief overview of the legal framework at multilateral, regional and national level. This was followed by an interactive session led by a practitioner who presented and discussed a number of practical cases. The final discussion provided an opportunity to look at matters of public interest and concerns with respect to the design and application of patentability criteria at country level and potential repercussions on public health.
The Workshop took place back to back with the WHO-WIPO-WTO Symposium on “Public Health, Intellectual Property, and TRIPS at 20: Innovation and Access to Medicines; Learning from the Past, Illuminating the Future” that was held at the WTO on 28 October 2015.
PROGRAMME
14h00 — 14h10 |
Welcome and introduction |
14h10 — 15h15 |
Patentability criteria and public health Patentability criteria pursuant to the TRIPS Agreement Patentability criteria and patent grant procedures at country level Impact of patentability criteria on public health Q&A |
15h15 — 17h00 |
Application of patentability criteria to concrete pharmaceutical patent cases Markus Engelhard, Boehmert & Boehmert, Munich/Germany |
17h00 — 18h00 |
Open discussion on patentability criteria and domestic needs Moderator: Antony Taubman, Director, Intellectual Property Division, WTO |